Biopharmaceutical company.
H.R. 3723: Viral Hepatitis Testing Act.

Implementation of Affordable Care Act as it relates to a regulatory pathway for biosimilars. Education and outreach about the competitive elements of the Medicare Part D drug benefit and opposition to legislation imposing Medicaid style manufacturer rebates in the program.
H.R. 4302: Protecting Access to Medicare Act of 2014.
H.R. 4160: Keep the Promise to Seniors Act of 2014.CMS proposed rule affecting the Medicare Advantage and Medicare Prescription Drug Benefit (Part D) Programs, specifically as it relates to changes to the Part D programs, including coverage of therapeutic classes and non interference. Monitored legislative efforts to reform the corporate tax system.
HCR - Health Issues MMM - Medicare/Medicaid TAX - Taxation/Internal Revenue Code
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX